COLYTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Colyte, and what generic alternatives are available?
Colyte is a drug marketed by Mylan Speciality Lp and is included in one NDA.
The generic ingredient in COLYTE is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COLYTE?
- What are the global sales for COLYTE?
- What is Average Wholesale Price for COLYTE?
Summary for COLYTE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 328 |
Clinical Trials: | 6 |
Patent Applications: | 2,454 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for COLYTE |
What excipients (inactive ingredients) are in COLYTE? | COLYTE excipients list |
DailyMed Link: | COLYTE at DailyMed |
![COLYTE drug patent expirations Drug patent expirations by year for COLYTE](/p/graph/s/t/COLYTE-patent-expirations.png)
![Drug Prices for COLYTE](/p/graph/drug-price/COLYTE.png)
![Drug Sales Revenue Trends for COLYTE](/p/graph/drug-sales-revenues/COLYTE.png)
Recent Clinical Trials for COLYTE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Incheon St.Mary's Hospital | Phase 3 |
Seoul National University Hospital | Phase 3 |
Inje University | N/A |